IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 265 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.49 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $747,000 | +522.5% | 124,691 | +256.3% | 0.04% | +218.2% |
| Q4 2020 | $120,000 | +287.1% | 35,000 | -13.2% | 0.01% | +120.0% |
| Q3 2020 | $31,000 | +158.3% | 40,300 | -11.4% | 0.01% | +150.0% |
| Q2 2020 | $12,000 | -99.6% | 45,500 | -81.4% | 0.00% | -99.7% |
| Q1 2020 | $3,393,000 | +5120.0% | 244,106 | +1219.5% | 0.78% | +12883.3% |
| Q4 2019 | $65,000 | +30.0% | 18,500 | -73.9% | 0.01% | -53.8% |
| Q3 2019 | $50,000 | – | 70,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,944,201 | $27,999,000 | 13.31% |
| Broadfin Capital, LLC | 4,328,303 | $41,162,000 | 8.50% |
| GREAT POINT PARTNERS LLC | 5,567,348 | $52,945,000 | 5.24% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $20,811,000 | 5.01% |
| Avoro Capital Advisors LLC | 10,530,862 | $100,148,000 | 4.33% |
| Prosight Management, LP | 917,080 | $8,721,000 | 3.82% |
| Perceptive Advisors | 12,235,811 | $116,362,000 | 3.28% |
| Ghost Tree Capital, LLC | 1,150,000 | $10,937,000 | 2.86% |
| QVT Financial LP | 1,021,361 | $9,241,000 | 2.32% |
| Cheyne Capital Management (UK) LLP | 186,500 | $1,774,000 | 1.66% |